Categories
Archives
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- June 2014
- May 2014
- April 2014
- March 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- March 2010
- February 2010
- January 2010
< Back to Press Releases
Monthly Archives: September 2015
Social deprivation and gender affects incidence of Hodgkin lymphoma in children and young adults
Vienna, Austria: Living in overcrowded conditions appears to protect children and young adults against developing a particular type of Hodgkin lymphoma (HL), a cancer that originates from the lymphocytes (white blood cells). This protective effect seems to suggest that infections … Continue reading
Published Monday, September 28th, 2015 at 4:45 pm
Posted in Cancer
A cancer diagnosis while pregnant should not lead to treatment delay or pregnancy termination
Vienna, Austria: Women who are pregnant when diagnosed with cancer can start treatment for their disease immediately and do not need to terminate their pregnancy due to worries over the effects of therapy on the development of their child. In … Continue reading
First ‘targeted’ treatment for small cell lung cancer shows promise
Vienna, Austria: Small cell lung cancer (SCLC) is an aggressive disease that is difficult to treat and is frequently only diagnosed when it has spread to other parts of the body (metastasised). Five-year survival rates in SCLC, which accounts for … Continue reading
Published Monday, September 28th, 2015 at 2:35 pm
Posted in Cancer
Drug combination improves progression-free survival in melanoma patients regardless of genetic status, age and spread of disease
Vienna, Austria: Patients with advanced melanoma skin cancer survive for longer without their disease progressing if they have been treated with a combination of two drugs, nivolumab and ipilimumab, than with either of these drugs alone. New results show that … Continue reading
Hormonal therapy could prevent ovarian failure and preserve fertility in women with breast cancer
Vienna, Austria: Young women undergoing chemotherapy for breast cancer may be more likely to remain fertile if they also receive hormonal treatment, according to new research presented to the 2015 European Cancer Congress [1] and published simultaneously in Annals of … Continue reading
Post diagnosis aspirin improves survival in all gastrointestinal cancers
Vienna, Austria: Aspirin improves survival in patients with tumours situated throughout the gastrointestinal (GI) tract, results from a large study in The Netherlands show. This is the first time that survival data from patients with tumours in different GI locations … Continue reading
Published Monday, September 28th, 2015 at 12:01 am
Posted in Cancer
A combination of two targeted therapies results in melanoma patients living significantly longer: new results
Vienna, Austria: Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the combined therapy than patients treated with another drug, vemurafenib, … Continue reading
Published Monday, September 28th, 2015 at 12:01 am
Posted in Cancer
Nivolumab improves the proportion of lung cancer patients alive after more than a year
Vienna, Austria: Patients with a type of lung cancer called non-squamous non-small cell lung cancer (non-SQ NSCLC) have limited treatment options and a dismal prognosis once their disease has advanced and initial treatment with platinum-based chemotherapy has failed. Second-line treatment … Continue reading
Published Monday, September 28th, 2015 at 12:01 am
Posted in Cancer
Treatment of elderly patients with breast cancer varies between different countries throughout Europe
Vienna, Austria: First results from the largest international comparison of the treatment of elderly patients with breast cancer have shown there are substantial differences in the use of surgery, hormone therapy and chemotherapy between European countries. The European Registration of … Continue reading
Published Sunday, September 27th, 2015 at 12:01 am
Posted in Cancer
Discovery of differences between tumours of younger and older colorectal cancer patients may lead to better treatments
Vienna, Austria: Colorectal cancer (CRC) is on the rise among younger patients. Although some of the younger-onset cases can be explained by hereditary factors, the majority arise spontaneously. Researchers have now found that tumours in younger colorectal cancer patients may … Continue reading